FDA Finalizes Guidance for Drug Therapeutic Equivalence

The U.S. FDA has issued its final guidance document on evaluating therapeutic equivalence for drug products. This guidance clarifies the agency's approach to assigning therapeutic equivalence codes, which are vital for informing state health agencies, prescribers, and pharmacists. The codes, listed in the Orange Book, support appropriate drug selection and contribute to containing healthcare costs.